{"transactions":[{"id":946304,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T21:26:18.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":6354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":6354,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":6354},"source":{"system":"sec-edgar","filing":"0000905148-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000070/form4.xml","form_type":"4"}},{"id":946303,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Restricted Stock Units","published_at":"2026-01-06T21:26:18.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":5443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":5443,"derivative":{"underlying":"Common Stock","underlying_shares":5443},"source":{"system":"sec-edgar","filing":"0000905148-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000070/form4.xml","form_type":"4"}},{"id":1136970,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Options (Right to Buy)","published_at":"2025-05-22T20:15:38.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":42010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":42010,"derivative":{"exercise_price":0.2708,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":42010},"source":{"system":"sec-edgar","filing":"0000905148-25-001894","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825001894/form4.xml","form_type":"4"}},{"id":1136969,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Restricted Stock Units","published_at":"2025-05-22T20:15:38.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":68621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":68621,"derivative":{"underlying":"Common Stock","underlying_shares":68621},"source":{"system":"sec-edgar","filing":"0000905148-25-001894","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825001894/form4.xml","form_type":"4"}},{"id":1354118,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-11-22T17:30:13.000Z","date":"2024-11-21","kind":"purchase","planned":false,"acquired":true,"shares":35000,"price":1.1589,"value":40561.5,"ownership":{"direct":false,"nature":"By: Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.155 to $1.1602, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":10411024,"source":{"system":"sec-edgar","filing":"0000905148-24-003257","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824003257/form4.xml","form_type":"4"}},{"id":1374132,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-11-06T20:15:40.000Z","date":"2024-11-06","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.359,"value":27180.0,"ownership":{"direct":false,"nature":"By: Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.3564 to $1.3599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":10376024,"source":{"system":"sec-edgar","filing":"0000905148-24-002946","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824002946/form4.xml","form_type":"4"}},{"id":1374131,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-11-06T20:15:40.000Z","date":"2024-11-05","kind":"purchase","planned":false,"acquired":true,"shares":51200,"price":1.365,"value":69888.0,"ownership":{"direct":false,"nature":"By: Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01"},"balance_after":10356024,"source":{"system":"sec-edgar","filing":"0000905148-24-002946","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824002946/form4.xml","form_type":"4"}},{"id":1503558,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2024-05-23T23:14:04.000Z","date":"2024-05-23","kind":"exercise","planned":false,"acquired":false,"shares":65218,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By: KFDI-B LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2608720},"source":{"system":"sec-edgar","filing":"0000905148-24-001610","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001610/form4.xml","form_type":"4"}},{"id":1503557,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2024-05-23T23:14:04.000Z","date":"2024-05-23","kind":"exercise","planned":false,"acquired":false,"shares":43478,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By: Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1739120},"source":{"system":"sec-edgar","filing":"0000905148-24-001610","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001610/form4.xml","form_type":"4"}},{"id":1503556,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Options (Right to Buy)","published_at":"2024-05-23T23:14:04.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":37050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":37050,"derivative":{"exercise_price":1.57,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":37050},"source":{"system":"sec-edgar","filing":"0000905148-24-001610","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001610/form4.xml","form_type":"4"}},{"id":1503555,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Restricted Stock Units","published_at":"2024-05-23T23:14:04.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":46686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":46686,"derivative":{"underlying":"Common Stock","underlying_shares":46686},"source":{"system":"sec-edgar","filing":"0000905148-24-001610","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001610/form4.xml","form_type":"4"}},{"id":1503554,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-05-23T23:14:04.000Z","date":"2024-05-23","kind":"exercise","planned":false,"acquired":true,"shares":2608720,"ownership":{"direct":false,"nature":"By: KFDI-B LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."}],"balance_after":2775386,"source":{"system":"sec-edgar","filing":"0000905148-24-001610","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001610/form4.xml","form_type":"4"}},{"id":1503553,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-05-23T23:14:04.000Z","date":"2024-05-23","kind":"exercise","planned":false,"acquired":true,"shares":1739120,"ownership":{"direct":false,"nature":"By: Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."}],"balance_after":12267873,"source":{"system":"sec-edgar","filing":"0000905148-24-001610","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001610/form4.xml","form_type":"4"}},{"id":1544475,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2024-04-09T23:32:08.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":65218,"price":46,"value":3000028.0,"ownership":{"direct":false,"nature":"By: KFDI-B LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."}],"balance_after":65218,"derivative":{"underlying":"Common Stock","underlying_shares":2608720},"source":{"system":"sec-edgar","filing":"0000905148-24-001138","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001138/form4.xml","form_type":"4"}},{"id":1544474,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2024-04-09T23:32:08.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":43478,"price":46,"value":1999988.0,"ownership":{"direct":false,"nature":"By: Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."}],"balance_after":43478,"derivative":{"underlying":"Common Stock","underlying_shares":1739120},"source":{"system":"sec-edgar","filing":"0000905148-24-001138","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001138/form4.xml","form_type":"4"}},{"id":1692039,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Restricted Stock Units","published_at":"2024-01-03T21:15:54.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":105389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":134262,"derivative":{"underlying":"Common Stock","underlying_shares":105389},"source":{"system":"sec-edgar","filing":"0000905148-24-000041","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824000041/form4.xml","form_type":"4"}},{"id":1813774,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-07T21:30:38.000Z","date":"2023-08-03","kind":"grant","planned":false,"acquired":true,"shares":6172839,"price":1.62,"value":9999999.18,"ownership":{"direct":false,"nature":"By: Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16"},"balance_after":10528753,"source":{"system":"sec-edgar","filing":"0000905148-23-000623","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000623/form4.xml","form_type":"4"}},{"id":1877967,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Restricted Stock Units","published_at":"2023-05-25T22:21:47.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":28873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":28873,"derivative":{"underlying":"Common Stock","underlying_shares":28873},"source":{"system":"sec-edgar","filing":"0001140361-23-026717","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123026717/form4.xml","form_type":"4"}},{"id":2062442,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Options (Right to Buy)","published_at":"2023-01-06T02:20:44.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":124998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option vests 40% on January 3, 2025, and the remaining 60% in 36 successive, equal monthly installments measured from January 3, 2025, generally subject to the Reporting Person's continued service on the Board through the applicable vesting date."}],"balance_after":124998,"derivative":{"exercise_price":2.05,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":124998},"source":{"system":"sec-edgar","filing":"0001140361-23-000727","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123000727/form4.xml","form_type":"4"}},{"id":2062441,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Restricted Stock Units","published_at":"2023-01-06T02:20:44.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":27408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service on the Board through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service on the Board through the applicable vesting date, and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents deferred RSUs.  The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer."}],"balance_after":27408,"derivative":{"underlying":"Common Stock","underlying_shares":27408},"source":{"system":"sec-edgar","filing":"0001140361-23-000727","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123000727/form4.xml","form_type":"4"}},{"id":2062440,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Restricted Stock Units","published_at":"2023-01-06T02:20:44.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":91463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on January 3, 2024, generally subject to the Reporting Person's continued service on the Issuer's board of directors (the \"Board\") through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on January 3, 2024, generally subject to the Reporting Person's continued service on the Issuer's board of directors (the \"Board\") through the applicable vesting date, and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents deferred RSUs.  The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer."}],"balance_after":91463,"derivative":{"underlying":"Common Stock","underlying_shares":91463},"source":{"system":"sec-edgar","filing":"0001140361-23-000727","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123000727/form4.xml","form_type":"4"}},{"id":2062439,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-01-06T02:05:36.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":2608696,"price":1.15,"value":3000000.4,"ownership":{"direct":false,"nature":"By: Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16"},"balance_after":4355914,"source":{"system":"sec-edgar","filing":"0001140361-23-000723","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123000723/form4.xml","form_type":"4"}},{"id":2062438,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-01-06T02:05:36.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":8260869,"price":1.15,"value":9499999.35,"ownership":{"direct":false,"nature":"By: Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reported amounts have been adjusted to reflect the September 27, 2022 transfer of 469,026 shares previously held by the Lair BDSX GRAT 2022-3.2 to the Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Exchange Act."}],"balance_after":9148889,"source":{"system":"sec-edgar","filing":"0001140361-23-000723","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123000723/form4.xml","form_type":"4"}}]}